Accurate clinical course descriptions (phenotypes) of multiple sclerosis (MS) are important
for communication, prognostication, design and recruitment of clinical trials, and treatment …

Diffusion tensor imaging (DTI) is an exciting new MRI modality that can reveal detailed anatomy
of the white matter. DTI also allows us to approximate the 3D trajectories of major white …

Background Interferon beta is used to modify the course of relapsing multiple sclerosis.
Despite interferon beta therapy, many patients have relapses. Natalizumab, an α 4 integrin …

Multiple sclerosis (MS) lesions that do not resolve in the months after they form harbour
ongoing demyelination and axon degeneration, and are identifiable in vivo by their …

Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has
demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). …

Background Fingolimod has shown reductions in clinical and MRI disease activity in patients
with relapsing-remitting multiple sclerosis. We further assessed the efficacy and safety of …

Background B lymphocytes are implicated in the pathogenesis of multiple sclerosis. We
aimed to assess efficacy and safety of two dose regimens of the humanised anti-CD20 …

PURPOSE: To examine the relation of visual function to retinal nerve fiber layer (RNFL)
thickness as a structural biomarker for axonal loss in multiple sclerosis (MS), and to compare …

We evaluated the safety, tolerability, pharmacodynamics, and activity of B‐cell depletion with
rituximab in patients with relapsing‐remitting multiple sclerosis, receiving two courses of …

We measured manual reaction time in normal human Ss to confirm that an eccentric visual
signal has a biphasic effect on covert attention and eye movements. First, it summons …